Novasep is a global contract development and manufacturing organization (CDMO) and technology provider serving the pharmaceutical and biopharmaceutical industries. The company focuses on process development, scale-up, and cGMP manufacture of complex small-molecule active pharmaceutical ingredients (APIs) and advanced intermediates.
Novasep is known for industrial-scale purification expertise, particularly chromatographic separation, including continuous chromatography, to isolate and purify compounds from complex mixtures. Its capabilities encompass highly potent APIs (HPAPIs), hazardous and multi-step chemistry, and integrated analytical and regulatory support from early development through commercial supply. Novasep operates multiple sites across Europe, Asia, and North America, supporting customers with development services, commercial manufacturing, and purification technologies.